Reply: Request for clarification on symptom assessment methodology in high-risk population colonoscopy study

Mingqing Zhang; Yongdan Zhang; Wen Zhang; Lizhong Zhao; Haoren Jing; Xiaojing Wu; Lu Guo; Haixiang Zhang; Yong Zhang; Siwei Zhu; Shiwu Zhang; Xipeng Zhang

doi:10.1002/cam4.6164

Reply: Request for clarification on symptom assessment methodology in high-risk population colonoscopy study

Cancer Med. 2023 Jul;12(14):15629-15631. doi: 10.1002/cam4.6164. Epub 2023 Jun 2.

Authors

Mingqing Zhang^{1

2

3

4}, Yongdan Zhang^{2

3}, Wen Zhang⁵, Lizhong Zhao^{2

3}, Haoren Jing^{2

3}, Xiaojing Wu⁴, Lu Guo⁵, Haixiang Zhang⁵, Yong Zhang⁵, Siwei Zhu^{1

2

3

4}, Shiwu Zhang^{4

6}, Xipeng Zhang^{1

2

3

4}

Affiliations

¹ Nankai University School of Medicine, Nankai University, Tianjin, China.
² Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
³ Tianjin Institute of Coloproctology, Tianjin, China.
⁴ The Institute of Translational Medicine, Tianjin Union Medical Center of Nankai University, Tianjin, China.
⁵ Center for Applied Mathematics, Tianjin University, Tianjin, China.
⁶ Department of Pathology, Tianjin Union Medical Center, Tianjin, China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Colonoscopy
Gastroesophageal Reflux*
Humans
Research Design
Risk Factors
Symptom Assessment